Venaxis (APPY) – StreetInsider.com Reports
-
Venaxis (APPY) Changes Name to Bioptix; Will Trade Under Ticker 'BIOP'
-
Venaxis (APPY) Halted on LUDP
-
Unusual 11 Mid-Day Movers 9/20: (TBRA) (GLMD) (DTSI) Higher; (ASNA) (HNI) (MGT) Lower
-
Unusual 11 Mid-Day Movers 9/14: (VTAE) (ACST) (SRPT) Higher; (LFVN) (RFIL) (RLGT) Lower
-
Venaxis (APPY) Acquires BiOptix
-
Pre-Open Stock Movers 05/18: (SAAS) (MZOR) (ANDE) Higher; (TGT) (VIPS) (ACXM) Lower (more...)
-
Venaxis (APPY) Gains Following MGT Stake
-
Venaxis (APPY), Strand Genomic Terminate Transaction Agreements
-
Venaxis (APPY) to Resume Trading at 4:40 PM ET
-
Venaxis (APPY) Enters Merger Agreement with Strand LS
-
Venaxis (APPY) Halted, News Pending
-
Notable Analyst Rating Changes 1/30: (JASO) (YHOO) (FL) Upgraded; (DGX) (APPY) (CX) Downgraded
-
Canaccord Genuity Downgrades AspenBio Pharma (APPY) to Hold
-
Craig-Hallum Downgrades AspenBio Pharma (APPY) to Hold
-
Notable 52-Week Highs and Lows 01/29: (JBLU) (BA) (HAR) High; (QCOM) (GEVO) (APPY) Low
-
Unusual 11 Mid-Day Movers 1/29: (GENE) (CRMD) (LRN) Higher; (APPY) (CTP) (PFMT) Lower
-
Venaxis (APPY) Reports FDA Denial of APPY1 Test 510(k) Submission
-
Venaxis, Inc. (APPY) Files $50M Mixed Shelf
-
Pre-Open Stock Movers 12/04: (ARRY) (PSUN) (TLYS) (NEE) Higher; (KIN) (UTIW) (GIL) Lower (more...)
-
After-Hours Stock Movers 12/03: (ARRY) (PSUN) (TLYS) (NEE) Higher; (KIN) (ARO) (VRNT) Lower (more...)
-
Venaxis, Inc. (APPY) Files Response with FDA Following Additional Information Request for APPY1
-
Pre-Open Stock Movers 10/28: (RCPT) (TRNX) (VDSI) (MSG) Higher; (TWTR) (AMKR) (CVLT) Lower (more...)
-
After-Hours Stock Movers 10/27: (TRNX) (RCPT) (SANM) Higher; (AKMR) (TWTR) (KSS) Lower (more...)
-
Venaxis, Inc. (APPY) Presents APPY1 Test Data at ACEP14
-
Unusual 11 Mid-Day Movers 07/16: (ZIPR) (NLST) (ICAD) Higher; (ININ) (BIOA) (LCI) Lower
-
Venaxis, Inc. (APPY) Files 10M Common, 3.5M Warrants Shelf
-
Venaxis, Inc. (APPY) Closes 8.34M Common Stock Offering
-
Catyalyst Pharma (CPRX) Prices 11.33M Common Offering at $2.21/Share
-
After-Hours Stock Movers 4/2 (PLUG) (EJ) (IRBT) Higher; (APPY) (BGMD) (CACI) Lower (more...)
-
Venaxis (APPY) Announces Common Stock Offering
-
Venaxis (APPY) Files for FDA Clearance of APPY1 Test
-
Notable 52-Week Highs and Lows of the Day 03/13: (ATVI) (APPY) (CALL) High; (HELI) (COVS) Low
-
Unusual 11 Mid-Day Movers 03/13: (TSRO) (LPHI) (APPY) Higher; (COVS) (AE) (AMRC) Lower
-
Streetinsider.com's Hot Lunchtime Reads 03/13: (FNMA) (EBAY) (UNIS) (APPY)
-
Aegis Capital Lifts PT on Venaxis (APPY) to $5; Sees Sustainable Profit Within ~12 Months
-
Pre-Open Stock Movers 3/13: (CALL) (APPY) (PLUG) Higher; (ITMN) (DG) (FIG) Lower (more...)
-
Venaxis (APPY) Ramps 20% on Positive Study Results
-
Venaxis (APPY) Announces Top-Line Results from APPY1 Test Study
-
Venaxis (APPY) to Discuss Top-Line Results from Study of APPY1 Test
-
Enrollment in Venaxis' (APPY) U.S. APPY1 Test = Completed
-
Venaxis (APPY) Files $20M Common Shelf
-
DSMB Recommends Continuination of Venaxis (APPY) Pivotal APPY1 Trial
-
Aegis Maintains Venaxis (APPY) at Buy, Cuts PT to $3.50 Following Recent Offering
-
Venaxis (APPY) Says DSMB Recommends Continuation of the Pivotal Clinical Trial
-
Venaxis (APPY) Stock Active
-
Venaxis (APPY) Supports JAMA Study Highlighting Cancer Risk of CT Scans
-
Venaxis (APPY) Prices Stock and Warrant Offering
-
StreetInsider.com Pre-Open Movers 03/27: (UTSI) (CHTP) (MFRM) Higher; (CLF) (LNDC) (FRAN) Lower (more...)
-
Streetinsider.com After-Hours Movers 3/26: (APPY) (SAI) (MFRM) Higher; (ISNS) (LNDC) (LOGM) Lower (more...)
-
Venaxis (APPY) Sees Enrollment in APPY1 Continuing Through Most of FY13
Back to APPY Stock Lookup